Cargando…

My continuing adventure with 21 CFR Part 11 - the evolution of Zymark's compliance

A renewed focus has been given to the 3-year-old regulation 21 CFR Part 11, Electronic Records and Electronic Signatures. This paper gives a chronology of the process of an equipment vendor, Zymark Corporation, validating laboratory automation equipment for compliance to the regulation 21 CFR Part 1...

Descripción completa

Detalles Bibliográficos
Autor principal: Dobro, Stephen M.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562856/
https://www.ncbi.nlm.nih.gov/pubmed/18924710
http://dx.doi.org/10.1155/S1463924601000232
_version_ 1782159767938007040
author Dobro, Stephen M.
author_facet Dobro, Stephen M.
author_sort Dobro, Stephen M.
collection PubMed
description A renewed focus has been given to the 3-year-old regulation 21 CFR Part 11, Electronic Records and Electronic Signatures. This paper gives a chronology of the process of an equipment vendor, Zymark Corporation, validating laboratory automation equipment for compliance to the regulation 21 CFR Part 11. Zymark's Tablet Processing Workstation II™ (TPW™) and Prelude™ are the instruments chronicled. The first instrument, the TPW™, was developed before Zymark defined its strategy on how to meet its customer's need for 21 CFR Part 11 compliant equipment. The TPW™ has been available for several years, and in the summer of 1999 it received a major software upgrade to improve its security. The second instrument, the Prelude™, is a new product. It had a design requirement to meet the regulation. Zymark's Part 11 strategy was already in place and used for this development project. This chronology will include all aspects of the exercise, including familiarization with the standard, development of the protocols, review of the protocols by industry experts, review of the protocols by pharmaceutical users, execution of the tests, preparation of the exception reports, and the release of any necessary product revisions.
format Text
id pubmed-2562856
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-25628562008-10-16 My continuing adventure with 21 CFR Part 11 - the evolution of Zymark's compliance Dobro, Stephen M. J Autom Methods Manag Chem Research Article A renewed focus has been given to the 3-year-old regulation 21 CFR Part 11, Electronic Records and Electronic Signatures. This paper gives a chronology of the process of an equipment vendor, Zymark Corporation, validating laboratory automation equipment for compliance to the regulation 21 CFR Part 11. Zymark's Tablet Processing Workstation II™ (TPW™) and Prelude™ are the instruments chronicled. The first instrument, the TPW™, was developed before Zymark defined its strategy on how to meet its customer's need for 21 CFR Part 11 compliant equipment. The TPW™ has been available for several years, and in the summer of 1999 it received a major software upgrade to improve its security. The second instrument, the Prelude™, is a new product. It had a design requirement to meet the regulation. Zymark's Part 11 strategy was already in place and used for this development project. This chronology will include all aspects of the exercise, including familiarization with the standard, development of the protocols, review of the protocols by industry experts, review of the protocols by pharmaceutical users, execution of the tests, preparation of the exception reports, and the release of any necessary product revisions. Hindawi Publishing Corporation 2001 /pmc/articles/PMC2562856/ /pubmed/18924710 http://dx.doi.org/10.1155/S1463924601000232 Text en Copyright © 2001 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Dobro, Stephen M.
My continuing adventure with 21 CFR Part 11 - the evolution of Zymark's compliance
title My continuing adventure with 21 CFR Part 11 - the evolution of Zymark's compliance
title_full My continuing adventure with 21 CFR Part 11 - the evolution of Zymark's compliance
title_fullStr My continuing adventure with 21 CFR Part 11 - the evolution of Zymark's compliance
title_full_unstemmed My continuing adventure with 21 CFR Part 11 - the evolution of Zymark's compliance
title_short My continuing adventure with 21 CFR Part 11 - the evolution of Zymark's compliance
title_sort my continuing adventure with 21 cfr part 11 - the evolution of zymark's compliance
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562856/
https://www.ncbi.nlm.nih.gov/pubmed/18924710
http://dx.doi.org/10.1155/S1463924601000232
work_keys_str_mv AT dobrostephenm mycontinuingadventurewith21cfrpart11theevolutionofzymarkscompliance